Defining a cohort of men who may not require repeat prostate biopsy based on PCA3 score and MRI: The dual negative effect
The Journal of Urology Dec 05, 2017
Perlis N, et al. - The goal of this research was to inspect how well the multiparametric MRI (mpMRI) and the PCA3 urine test performed in combination for men with previous biopsies. It was observed that clinically significant Prostate Cancer (PCa) was never detected on biopsy, in patients with dual negative tests (mpMRI and PCA3 score). These could be regarded as unnecessary in this group. This research displayed limitation owing to its retrospective design, selection bias and lack of cost-effectiveness data.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
